Serum sialic acid and CEA concentrations in human breast cancer.
The concentration of bound sialic acid in the sera of 56 normal subjects and 65 subjects with breast cancer was measured, in order to determine (1) whether serum sialic acid concentrations are raised in breast cancer and (2) whether the concentration of sialic acid in serum reflects tumour stage. The amount of sialic acid in serum was compared to serum carcinoembryonic antigen (CEA) values. Urinary hydroxyproline and serum alkaline phosphatase concentrations were used as indicators of bone and liver involvement. Erythrocyte sedimentation rate (ESR) was also measured. Significantly elevated serum sialic acid concentrations were found in breast cancer, and showed correlation with tumour stage. Serum sialic acid values did not correlate with CEA values. The results suggest that measurement of serum sialic acid concentrations may be of adjunctive value in assessing tumour stage.
D000469:Alkaline Phosphatase / Q000097:blood; D001799:Blood Sedimentation; D001943:Breast Neoplasms / Q000097:blood* / Q000473:pathology / Q000652:urine; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D012794:Sialic Acids / Q000097:blood*
D002272:Carcinoembryonic Antigen; D012794:Sialic Acids; D000469:Alkaline Phosphatase; D006909:Hydroxyproline